|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/574 |
| (11) | Number of the document | 3234193 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15832934.2 |
| Date of filing the European patent application | 2015-12-21 | |
| (97) | Date of publication of the European application | 2017-10-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/067143 |
| Date | 2015-12-21 |
| (87) | Number | WO 2016/100975 |
| Date | 2016-06-23 |
| (30) | Number | Date | Country code |
| 201462124473 P | 2014-12-19 | US |
| (72) |
HACOHEN, Nir, US
ROONERY, Michael, S., US
|
| (73) |
The General Hospital Corporation,
55 Fruit Street, Boston, MA 02114,
US
Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02142, US |
| (54) | MOLECULAR BIOMARKERS FOR CANCER IMMUNOTHERAPY |
| MOLECULAR BIOMARKERS FOR CANCER IMMUNOTHERAPY |